Jin Li

This inventor holds 35 USPTO granted patents and 5 published patent applications and 2 EPO patents, primarily in Cancer Treatment Methods. Top assignees: Huawei Technologies Co., Limited, Citrix Systems, Inc., Syz Cell Therapy Co.. Active years: 2010-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jin Li. Retrieved from https://idiyas.com/inventor/jin-li-po6fhzcs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 35 (Patent Applications = 5)

% Patents Active = 85.7

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 2.9

ph-index = 4

Forward Citations = 61(Granted Patents)

Location History:

Wuhan, CN (2016 - 2020)
Guangdong, CN (2021 - 2022)
Dongguan, CN (2022)
Shenzhen, CN (2010 - 2023)
Hubei, CN (2015 - 2023)
Nanjing, CN (2013 - 2024)

Company Filing History:

14 out of 27,557

Huawei Technologies Co., Limited

Fih (Hong Kong) Limited

patents

5. 3 out of 860

Shenzhen Futaihong Precision Industry Co., Ltd.

patents

6. 3 out of 137

Stmicroelectronics (Shenzhen) R&d Co. Ltd.

Hryz (Shenzhen) Biotech Co.

patents

9. 1 out of 865

Huawei Device Co., Ltd.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.

patents

12. 1 out of 13

Wuhan Textile University

patents

13. 2 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2010-2024

Loading Chart...

Areas of Expertise:

Cancer Treatment

Imidazo Compounds

Meeting Room Reservation

Cell Therapy

Data Transmission

Wireless Networking

Virtual Machine Migration

Short-Circuit Protection

Bandwidth Allocation

Optical Line Terminal

Construction Equipment

Network Policy Configuration

35 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12024511 - Substituted imidazo[1,2-a]pyridin-2-ylamine compounds, and pharmaceutical compositions and methods of use thereof (2024-07-02),

2. 11962428 - Meeting room reservation system and related techniques (2024-04-16),

3. 11785090 - Linkage control system and method, storage medium, and electronic device (2023-10-10),

4. 11655641 - Construction building equipment and construction method thereof (2023-05-23),

5. 11429551 - Board of optical line terminal and optical line terminal (2022-08-30),

6. 11251983 - Meeting room reservation system and related techniques (2022-02-15),

7. 11248208 - Multiple antigen specific cell therapy methods (2022-02-15),

8. 11240164 - Method for obtaining path information of data packet and device (2022-02-01),

9. 11229689 - Methods of cancer treatment using activated T cells (2022-01-25),

10. 11219675 - Methods of cancer treatment using activated T cells (2022-01-11),

11. 11205060 - Loopback mode for bypassing a camera of an apparatus (2021-12-21),

12. 11159848 - Video playing method, device, and system (2021-10-26),

13. 11134001 - Data distribution method and distribution server (2021-09-28),

14. 10967054 - Methods of cancer treatment using activated T cells (2021-04-06),

15. 10924423 - Adaptive mechanism to adjust UDT packet size based on actual network condition (2021-02-16),

Title: The Innovative Journey of Jin Li: A Pioneer in Pharmaceutical and Technological Advancements

Introduction: Jin Li, located in Nanjing, China, is a renowned inventor with an impressive portfolio of 35 patents. His work spans various fields, including pharmaceuticals and technology, highlighting his contributions to innovative solutions that address critical challenges in healthcare and everyday technological applications.

Latest Patents: Among Jin Li's latest patents are two notable inventions. The first is related to substituted imidazo[1,2-a]pyridin-2-ylamine compounds and their pharmaceutical compositions. This groundbreaking work presents innovative compounds designed for the treatment, prevention, or amelioration of Janus kinase-mediated diseases. The second patent details techniques for a meeting room reservation system that integrates the booking of rooms and media resources. This methodology allows users to access display devices seamlessly through a secure token system, enhancing the efficiency of room usage in corporate and institutional settings.

Career Highlights: Jin Li has collaborated with esteemed organizations such as Huawei Technologies Co., Limited and Syz Cell Therapy Co. These affiliations have provided him with a strong foundation in both technological and medical advancements, furthering his capabilities as an inventor. His deep understanding of complex scientific principles has enabled him to develop practical solutions with real-world applications.

Collaborations: Throughout his career, Jin Li has worked alongside talented individuals, including colleagues Feng Li and Yue Yin. These collaborations have fostered a dynamic environment for innovation, allowing for the exchange of ideas and fostering advancements in various domains. Together, they contribute to a culture of innovation aimed at solving pressing global issues.

Conclusion: Jin Li's contributions to the fields of pharmaceuticals and technology exemplify the spirit of innovation that drives progress. With a notable collection of patents and a track record of meaningful collaborations, he continues to pave the way for future advancements that hold the potential to significantly impact industries and improve lives.

Profile summary based on public USPTO records.